For laboratory research use only. Not for human or veterinary use.
⚠ For research purposes only — This certificate relates to the referenced lot only and is not an approval for human or veterinary use.
← Back to NAD+
All certificates
Atlas LabsQuality Control · Released Records

Certificate of Analysis

DOC QC-COA-0105-A2610 · REV 1
ProductNAD+
SKUATL-0105
LotA2610
FormatLyophilized · 500 mg
TestedJul 2026
Retest datePLACEHOLDER
CAS53-84-9
Storage−20 °C · desiccated
DispositionRELEASED

Test results

Release test results for NAD+ lot A2610
TestMethodSpecificationResultVerdict
AppearanceVisual White to off-white solidWhite lyophilized solid PASS
PurityRP-HPLC, 220 nm ≥ 95.0%99.36% PASS
Net peptide contentHPLC 500 mg ± 2%503.1 mg PASS
IdentityESI-MS Observed mass conforms to theoreticalConforms PASS
Fentanyl screenImmunoassay Not detectedNot detected PASS
Heavy metalsICP-MS Not detectedNot detected PASS
SterilityPCR No growthNo growth PASS
EndotoxinLAL, USP <85> < 0.5 EU/mL< LOD PASS

Chromatogram · RP-HPLC, 220 nm

12.4 min · 99.36% RRT 1.28 · 0.09% 01530 min
FIG 1 · MAIN PEAK 12.4 MIN, 99.36% AREA · LARGEST IMPURITY 0.09% · PLACEHOLDER TRACE, REPLACE WITH LAB EXPORT

Conclusion. Lot A2610 of ATL-0105 meets all release specifications and is approved for distribution for laboratory research use only. Testing performed by ILS Laboratories, an independent ISO 17025 accredited laboratory.

Analyst · PLACEHOLDERILS Laboratories · Jul 2026
QC Release · PLACEHOLDERAtlas Labs · Jul 2026
VERIFY THIS DOCUMENT
getatlaspeptides.com/coa/a2610
CODE ATL-A2610-1V5Z